HONG KONG, Jun 1, 2022 - (ACN Newswire) - - TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to ...
Jefferies analyst Chris Lui maintained a Buy rating on TOT BIOPHARM International Co. Ltd. (1875 – Research Report) on October 25 and set a price target of HK$2.40. The company’s shares closed last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results